Market Overview

Seeing Limited Catalysts Ahead, UBS Powers Down Lear

Seeing Limited Catalysts Ahead, UBS Powers Down Lear

Although Lear Corporation (NYSE: LEA) is well positioned in the tough macro environment, price concessions may continue to exert pressure and the progress at E-Systems may to too gradual, according to UBS.

The Analyst

UBS analyst Colin Langan downgraded the rating on Lear from Buy to Neutral while reducing the price target from $158 to $135.

The Thesis

Although the E-Systems business could improve margins going ahead, driving Lear’s overall margin expansion, the process is likely to be gradual, Langan said in the downgrade note.

He added that there is unlikely to be any meaningful improvement until mid-2020.

Lear has guided to E-Systems margin at mid-8%. Given the company’s history of above-average margin performance, there could be upside to this forecast.

Langan added, however, that the Lear’s fiscal 2019 guidance suggests that margins at E-Systems would be mid-7% in the back half of the year.

This is around 700 basis points below peak margins.

“We expect that until LEA is able to show margin expansion, investors will be sidelined,” the analyst wrote.

Although Lear is one of the best positioned in a recession scenario, given its strong balance sheet and free cash flows, recession risks cannot be ignored, Langan said. He added that the price concessions introduced by the company in the front half of 2019 could continue to weigh on performance.

Price Action

Shares of Lear had declined 0.28% to $126.05 at the time of publishing.

Related Links
Benzinga's Top Upgrades, Downgrades For September 12, 2019
10 Biggest Price Target Changes For Thursday

Latest Ratings for LEA

Sep 2019DowngradesBuyNeutral
Aug 2019MaintainsOverweight
Jul 2019MaintainsNeutral

View More Analyst Ratings for LEA
View the Latest Analyst Ratings

Posted-In: Colin Langan UBSAnalyst Color Downgrades Price Target Analyst Ratings


Related Articles (LEA)

View Comments and Join the Discussion!

Latest Ratings

HSKACanaccord GenuityMaintains75.0
AVGOMorgan StanleyMaintains265.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Why THCV, One Of The Many Compounds In Cannabis, Might Be The Next Big Thing In Weed

KeyBanc Upgrades Kaman On Potential M&A Moves